Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry

[1]  E. Nikiphorou,et al.  Comorbidities and extra-articular manifestations in difficult-to-treat rheumatoid arthritis: different sides of the same coin? , 2022, Rheumatology.

[2]  M. Charlson,et al.  Charlson Comorbidity Index: A Critical Review of Clinimetric Properties , 2022, Psychotherapy and Psychosomatics.

[3]  M. Dougados,et al.  EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis , 2021, Annals of the Rheumatic Diseases.

[4]  R. Westhovens,et al.  Comorbidity burden in the first three years after diagnosis in patients with rheumatoid arthritis, psoriatic arthritis or spondyloarthritis: a general practice registry-based study , 2021, RMD Open.

[5]  J. Jacobs,et al.  Non-adherence in difficult-to-treat rheumatoid arthritis from the perspectives of patients and rheumatologists: a concept mapping study. , 2021, Rheumatology.

[6]  H. Sayles,et al.  Burden and trajectory of multimorbidity in rheumatoid arthritis: a matched cohort study from 2006 to 2015 , 2020, Annals of the Rheumatic Diseases.

[7]  S. de Lusignan,et al.  Prognostic value of comorbidity indices and lung diseases in early rheumatoid arthritis: a UK population-based study , 2019, Rheumatology.

[8]  N. Goodson,et al.  Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis , 2018, Rheumatology.

[9]  D. Elashoff,et al.  Joint-specific assessment of swelling and power Doppler in obese rheumatoid arthritis patients , 2017, BMC Musculoskeletal Disorders.

[10]  M. Dougados,et al.  Treatment Patterns of Multimorbid Patients with Rheumatoid Arthritis: Results from an International Cross-sectional Study , 2015, The Journal of Rheumatology.

[11]  H. Sayles,et al.  Validation of the Rheumatic Disease Comorbidity Index , 2015, Arthritis care & research.

[12]  A. Taniguchi,et al.  Presence of comorbidity affects both treatment strategies and outcomes in disease activity, physical function, and quality of life in patients with rheumatoid arthritis , 2015, Clinical Rheumatology.

[13]  A. Bottle,et al.  Systematic Review of Comorbidity Indices for Administrative Data , 2012, Medical care.

[14]  S. Bae,et al.  Impact of comorbidities on TNF inhibitor persistence in rheumatoid arthritis patients: an analysis of Korean National Health Insurance claims data , 2012, Rheumatology International.

[15]  D. Symmons,et al.  2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. , 2010, Arthritis and rheumatism.

[16]  Tanja Stamm,et al.  Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. , 2005, Arthritis and rheumatism.

[17]  A R Feinstein,et al.  THE PRE-THERAPEUTIC CLASSIFICATION OF CO-MORBIDITY IN CHRONIC DISEASE. , 1970, Journal of chronic diseases.

[18]  P. Dieudé,et al.  Overweight and obesity affect clinical assessment of synovitis in rheumatoid arthritis: comparison of ultrasonography and clinical exam. , 2019, Clinical and experimental rheumatology.

[19]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[20]  C. Werning.  [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.